[ad_1]
In Latvia, highly optimistic, the State Council of Immunization Chairperson Day Sawadzka has opened for the “lsm.lv” portal that vaccination against Kovid-19 will begin in February.
Once the vaccine is registered with the European Medicines Agency, it takes at least two weeks for the vaccine to be delivered first to EU countries and then to vaccination offices. “So, with a lot of optimism, we can start vaccinating in February,” Savadska said.
These vaccines are not available for a fee, including at private clinics. Immunizations will be given to all high-risk groups, including doctors, people over 60, police officers and teachers. “If we see that vaccines are still left, we will expand the circle in which they become available, but private clinics will begin to create their own pay lines,” Svadowska said.
Initially, vaccinations will be conducted by hospitals, perhaps mobile teams. After that, large medical centers will gradually be included, but later family doctors as well.
According to the World Health Organization, the vaccine requirements of all countries will be met by September next year, said Yuri Perevoshikov, director of the Infectious Disease Risk Analysis and Prevention Department at the Center for Disease Prevention and Control (SPKC). “It’s not going to happen anytime soon, and there will be enough vaccines for everyone in January,” the experts added.
Regarding the duration of immunity, Savadska points out that some patients in the vaccine developers’ voluntary testing groups already had a full course of vaccination during the summer. Antibody levels do not appear to have decreased for them yet, but it is not yet clear whether immunity will last a year, two or five years. Now, this infection does not look like a lifelong vaccine.
It is unknown at this time what he will do after leaving the post. There are a number of epidemics that break out in waves once every three to five years, but the incidence of outbreaks is declining. Covid-19 is likely to be similar, with a large portion of the world’s population gradually gaining immunity through immunization or when they are sick.
Svadowska said three EU vaccine manufacturers – Pfizer, Modena and AstraZeneca – had applied for a speedy evaluation but would now be approved by the European Medicines Agency. Latvia has high hopes for all three vaccines.
Residents will not have to specifically decide which vaccines to receive. “One vaccine is more likely to be effective for the elderly and the other for the younger. We will evaluate it. However, in general, of course, specific options will not be chosen,” Savadska said.
The European Medicines Agency (EMA) has already received two applications this week from Bio Ntech and Pfizer for registering vaccines against Kovid-19, as well as from a pharmaceutical company called Modena.
Issa plans to recommend a vaccine developed by Biotech and Pfizer by December 29th and a “modern” vaccine by January 12th. If these vaccines are found to be effective, high quality and safe, the ESA will recommend that they be approved or registered with the European Commission. Once the vaccine is registered in the European Union (EU), it is available in the same doses in all EU member states at the same time, from a few weeks to a few months.
The Latvian Ministry of Health estimates that it will cost ിയ 26.7 million to vaccinate Latvians against Kovid-19 in 2021. These costs include the payment for vaccines, their delivery, logistics, and administration, and are planned to cover unexpected costs from the state budget.
Meanwhile, Secretary of State for Foreign Affairs Dina Murmane-Ambraco revealed on this week’s Latvian radio program “CrustPunks” that the first vaccines against Kovid-19 are expected to be available by Christmas or early next year.
She said it was initially planned to receive 6,000 vaccines, which would give doctors immunizations.
Source link
